Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes

NJ Hogrebe, M Ishahak, JR Millman - Cell Stem Cell, 2023‏ - cell.com
The generation of islet-like endocrine clusters from human pluripotent stem cells (hPSCs)
has the potential to provide an unlimited source of insulin-producing β cells for the treatment …

Induced pluripotent stem cell technology: a decade of progress

Y Shi, H Inoue, JC Wu, S Yamanaka - Nature reviews Drug discovery, 2017‏ - nature.com
Since the advent of induced pluripotent stem cell (iPSC) technology a decade ago,
enormous progress has been made in stem cell biology and regenerative medicine. Human …

Survivin at a glance

SP Wheatley, DC Altieri - Journal of cell science, 2019‏ - journals.biologists.com
Survivin (also known as BIRC5) is an evolutionarily conserved eukaryotic protein that is
essential for cell division and can inhibit cell death. Normally it is only expressed in actively …

Genomic instability of iPSCs: challenges towards their clinical applications

M Yoshihara, Y Hayashizaki, Y Murakawa - Stem cell reviews and reports, 2017‏ - Springer
Induced pluripotent stem cells (iPSCs) are a type of pluripotent stem cells generated directly
from mature cells through the introduction of key transcription factors. iPSCs can be …

The potential and limitations of induced pluripotent stem cells to achieve wound healing

J Gorecka, V Kostiuk, A Fereydooni, L Gonzalez… - Stem cell research & …, 2019‏ - Springer
Wound healing is the physiologic response to a disruption in normal skin architecture and
requires both spatial and temporal coordination of multiple cell types and cytokines. This …

Human autologous iPSC–derived dopaminergic progenitors restore motor function in Parkinson's disease models

B Song, Y Cha, S Ko, J Jeon, N Lee, H Seo… - The Journal of clinical …, 2020‏ - jci.org
Parkinson's disease (PD) is a neurodegenerative disorder associated with loss of striatal
dopamine, secondary to degeneration of midbrain dopamine (mDA) neurons in the …

Combinatorial therapies after spinal cord injury: how can biomaterials help?

T Führmann, PN Anandakumaran… - Advanced healthcare …, 2017‏ - Wiley Online Library
Traumatic spinal cord injury (SCI) results in an immediate loss of motor and sensory function
below the injury site and is associated with a poor prognosis. The inhibitory environment that …

Injectable hydrogel promotes early survival of induced pluripotent stem cell-derived oligodendrocytes and attenuates longterm teratoma formation in a spinal cord …

T Führmann, RY Tam, B Ballarin, B Coles… - Biomaterials, 2016‏ - Elsevier
Transplantation of pluripotent stem cells and their differentiated progeny has the potential to
preserve or regenerate functional pathways and improve function after central nervous …

Past, present, and future of cell replacement therapy for parkinson's disease: a novel emphasis on host immune responses

TY Park, J Jeon, Y Cha, KS Kim - Cell Research, 2024‏ - nature.com
Parkinson's disease (PD) stands as the second most common neurodegenerative disorder
after Alzheimer's disease, and its prevalence continues to rise with the aging global …

Improving the safety of human pluripotent stem cell therapies using genome-edited orthogonal safeguards

RM Martin, JL Fowler, MK Cromer, BJ Lesch… - Nature …, 2020‏ - nature.com
Despite their rapidly-expanding therapeutic potential, human pluripotent stem cell (hPSC)-
derived cell therapies continue to have serious safety risks. Transplantation of hPSC-derived …